VC firm · US · symbiosis.vc

SymBiosis

Last cheque observed Aug 2026; 3 cheques observed across the 16 sources we track.

deployingwebsite livecoverage medium

What they say, and what they did

They say

Type
VC firm
Cheque size
not stated
Stages
Series A, Series B, Growth
Cold pitches
accepted

From their own site: “We partner with innovators building groundbreaking companies with the following characteristics Life-Threatening Disease With Hard Endpoint ... Novel Therapeutic Platform In Any Modality ... Lead Reaching Human Proof-Of-Concept ... Designed for manufacturability”

We observed

Rounds they appear in
3 (2 led)
Median round size
$78M not their cheque
Sole named investor
never
Last seen
Aug 2026

An announcement gives the size of the round, not the size of this investor's cheque. The only rounds that imply a cheque are those where they were the sole named investor.

The record

CompanyStageRoleRoundWhen
FORE BiotherapeuticsUS · Ventureburn
Series Dled$67MAug 2026
R1 TherapeuticsUS · TechStartups
Series Awith 5 others$78MMar 2026
AdvanCellAU · Startup Daily
Series Cled$112MFeb 2025

Every row links the article it came from · 3 appearances recorded

Something wrong here? Tell us — corrections are free and need no account.